GABA function in mood disorders: an update and critical review (Q40840213)

24 September 2017

1 reference

title

GABA function in mood disorders: an update and critical review (English)

1 reference

24 September 2017

1 reference

Shiah IS

1

1 reference

24 September 2017

Yatham LN

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

24 September 2017

15

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

24 September 2017

63

1 reference

24 September 2017

15

1 reference

24 September 2017

1289-1303

1 reference

GABA and behavior: the role of receptor subtypes

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA receptors: are cellular differences reflected in function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The gabaergic hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA and mood disorders: a brief review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Failure to escape traumatic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABAergic modulation of learned helplessness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Additivity of neurochemical changes in learned helplessness and imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Neurochemical basis of the action of antidepressants on learned helplessness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Noradrenergic rather than GABAergic processes as the common mediation of the antidepressant profile of GABA agonists and imipramine-like drugs in animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Differential effects of olfactory bulbectomy on GABAA and GABAB receptors in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA levels in CSF of patients with psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

CSF GABA in depressed patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

CSF GABA in euthymic manie-depressive patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Amino acid levels in depression: a preliminary investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Relationship between GABA concentrations in cerebrospinal fluid and seizure excitability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Effect of drugs on rat brain, cerebrospinal fluid and blood GABA content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The relationship between GABA concentrations in brain and cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma and CSF GABA in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma GABA in affective illness. A preliminary investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma GABA levels in psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Low plasma gamma-aminobutyric acid levels in male patients with depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Low plasma GABA is a trait-like marker for bipolar illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma glutamate decarboxylase activity in neuropsychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Platelet GABA-transaminase in affective illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA concentrations in forebrain areas of suicide victims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Brain GABAB binding sites in depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Neural control of somatotropic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Stimulatory Effect of Acute Baclofen Administration on Human Growth Hormone Secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Reduction of GH response to the GABA-B agonist baclofen in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Growth hormone response to the GABAB agonist baclofen in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma GABA predicts acute response to divalproex in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Sodium valproate in schizophrenia: some biochemical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Plasma GABA levels in neurological patients under treatment with valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Increase of human plasma GABA by sodium valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Benzodiazepine-GABAA Receptors in Idiopathic Generalized Epilepsy Measured with [11C]Flumazenil and Positron Emission Tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Effects of Divalproex Sodium on 5-HT1A Receptor Function in Healthy Human Males: Hypothermic, Hormonal, and Behavioral Responses to Ipsapirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Parallel changes in the sensitivity of gamma-aminobutyric acid and noradrenergic receptors following chronic administration of antidepressant and GABAergic drugs. A possible role in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Antidepressant-anxiolytic interaction: Decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up-regulates GABAB receptor binding sites in rat frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Are increases in GABAB receptors consistent findings following chronic antidepressant administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Differential effects of antidepressants on GABAB and β-adrenergic receptors in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Lack of effect of bilateral locus coeruleus lesion and antidepressant treatment on gamma-aminobutyric acidB receptors in the rat frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Functional evidence for altered activity of GABAergic receptors following chronic desipramine treatment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Differential effects of chronic antidepressants in behavioural tests of β-adrenergic and GABAB receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Involvement of GABAB receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Desipramine does not alter plasma GABA in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Evidence for GABA control of serotonin metabolism in the rat suprachiasmatic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The effects of the GABA-mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxytryptamine and noradrenaline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The administration of baclofen to mice increases 5-HT2-mediated head-twitch behaviour and 5-HT2 receptor number in frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Benzodiazepines as antidepressants: does GABA play a role in depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Use of clonazepam in mania and schizoaffective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Clonazepam Treatment of Atypical Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Clonazepam in acute mania: a double blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Gabapentin in the treatment of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

Acute treatment of bipolar depression with gabapentin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900241-0

10.1016/S0024-3205(98)00241-0

7 January 2021

Identifiers

DOI

1 reference

release_auvbwire2nfeve2vrgtxwnw7im

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/auvbwire2nfeve2vrgtxwnw7im

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference